# YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness

> **NCT01028950** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 52 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** YM150

## Key facts

- **NCT ID:** NCT01028950
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2010-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028950, "YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01028950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*